Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/fa0344d0725b4c7788695fafcc3f18e8 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:fa0344d0725b4c7788695fafcc3f18e8 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:fa0344d0725b4c7788695fafcc3f18e82021-11-12T13:00:05ZPembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates10.1136/jitc-2021-0031222051-1426https://doaj.org/article/fa0344d0725b4c7788695fafcc3f18e82021-09-01T00:00:00Zhttps://jitc.bmj.com/content/9/9/e003122.fullhttps://doaj.org/toc/2051-1426Mary L DisisJohn B LiaoDoreen M HigginsJennifer S ChildsSasha E StantonAnna V TinkerWilliam R GwinRenata R UrbanKatie M Hitchcock-BernhardtAndrew L CovelerHania N ShakaliaRon E SwensenTanya A WahlRichard G AnchetaKathryn F McGonigleJames Y DaiBarbara A GoffBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
| spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Mary L Disis John B Liao Doreen M Higgins Jennifer S Childs Sasha E Stanton Anna V Tinker William R Gwin Renata R Urban Katie M Hitchcock-Bernhardt Andrew L Coveler Hania N Shakalia Ron E Swensen Tanya A Wahl Richard G Ancheta Kathryn F McGonigle James Y Dai Barbara A Goff Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates |
| format |
article |
| author |
Mary L Disis John B Liao Doreen M Higgins Jennifer S Childs Sasha E Stanton Anna V Tinker William R Gwin Renata R Urban Katie M Hitchcock-Bernhardt Andrew L Coveler Hania N Shakalia Ron E Swensen Tanya A Wahl Richard G Ancheta Kathryn F McGonigle James Y Dai Barbara A Goff |
| author_facet |
Mary L Disis John B Liao Doreen M Higgins Jennifer S Childs Sasha E Stanton Anna V Tinker William R Gwin Renata R Urban Katie M Hitchcock-Bernhardt Andrew L Coveler Hania N Shakalia Ron E Swensen Tanya A Wahl Richard G Ancheta Kathryn F McGonigle James Y Dai Barbara A Goff |
| author_sort |
Mary L Disis |
| title |
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates |
| title_short |
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates |
| title_full |
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates |
| title_fullStr |
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates |
| title_full_unstemmed |
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates |
| title_sort |
pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates |
| publisher |
BMJ Publishing Group |
| publishDate |
2021 |
| url |
https://doaj.org/article/fa0344d0725b4c7788695fafcc3f18e8 |
| work_keys_str_mv |
AT maryldisis pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT johnbliao pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT doreenmhiggins pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT jenniferschilds pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT sashaestanton pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT annavtinker pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT williamrgwin pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT renatarurban pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT katiemhitchcockbernhardt pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT andrewlcoveler pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT hanianshakalia pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT roneswensen pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT tanyaawahl pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT richardgancheta pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT kathrynfmcgonigle pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT jamesydai pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates AT barbaraagoff pembrolizumabwithlowdosecarboplatinforrecurrentplatinumresistantovarianfallopiantubeandprimaryperitonealcancersurvivalandimmunecorrelates |
| _version_ |
1718430534860800000 |